ES2171742T3 - Agente reductor de la presion ocular. - Google Patents

Agente reductor de la presion ocular.

Info

Publication number
ES2171742T3
ES2171742T3 ES96938475T ES96938475T ES2171742T3 ES 2171742 T3 ES2171742 T3 ES 2171742T3 ES 96938475 T ES96938475 T ES 96938475T ES 96938475 T ES96938475 T ES 96938475T ES 2171742 T3 ES2171742 T3 ES 2171742T3
Authority
ES
Spain
Prior art keywords
reducing agent
ocular
pressure reducing
agent
ocular tension
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES96938475T
Other languages
English (en)
Inventor
Hajimu Kurumatani
Ayako Kawashima
Masafumi Isogaya
Hisanori Wakita
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Toray Industries Inc
Original Assignee
Toray Industries Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Toray Industries Inc filed Critical Toray Industries Inc
Application granted granted Critical
Publication of ES2171742T3 publication Critical patent/ES2171742T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
    • A61K31/558—Eicosanoids, e.g. leukotrienes or prostaglandins having heterocyclic rings containing oxygen as the only ring hetero atom, e.g. thromboxanes
    • A61K31/5585—Eicosanoids, e.g. leukotrienes or prostaglandins having heterocyclic rings containing oxygen as the only ring hetero atom, e.g. thromboxanes having five-membered rings containing oxygen as the only ring hetero atom, e.g. prostacyclin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/06—Antiglaucoma agents or miotics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/93—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems condensed with a ring other than six-membered

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Eye Examination Apparatus (AREA)
  • Medicinal Preparation (AREA)
  • Prostheses (AREA)
  • Window Of Vehicle (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Laser Surgery Devices (AREA)

Abstract

ESTA INVENCION SE REFIERE A UN AGENTE PARA REDUCIR LA TENSION OCULAR QUE CONTIENE COMO INGREDIENTE EFECTIVO UN DERIVADO DEL PGL{SUB,2} DE 4,8 - INTER - M - FENILENO REPRESENTADO POR LA FORMULA: O UNA SAL FARMACEUTICAMENTE ACEPTABLE DEL MISMO. EL AGENTE PARA REDUCIR LA TENSION OCULAR DE LA PRESENTE INVENCION ES UTIL COMO AGENTE TERAPEUTICO PARA EL TRATAMIENTO DE VARIOS ESTADOS DE TENSION OCULAR ELEVADA TALES COMO EL GLAUCOMA, HIPERTENSION OCULAR Y TENSION RESULTANTES DE UNA OPERACION QUIRURGICA.
ES96938475T 1995-11-14 1996-11-14 Agente reductor de la presion ocular. Expired - Lifetime ES2171742T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP29578995 1995-11-14

Publications (1)

Publication Number Publication Date
ES2171742T3 true ES2171742T3 (es) 2002-09-16

Family

ID=17825188

Family Applications (1)

Application Number Title Priority Date Filing Date
ES96938475T Expired - Lifetime ES2171742T3 (es) 1995-11-14 1996-11-14 Agente reductor de la presion ocular.

Country Status (11)

Country Link
US (1) US6127413A (es)
EP (1) EP0795331B1 (es)
KR (1) KR19980701417A (es)
CN (1) CN1127342C (es)
AT (1) ATE215824T1 (es)
AU (1) AU717104B2 (es)
CA (1) CA2210255A1 (es)
DE (1) DE69620573T2 (es)
ES (1) ES2171742T3 (es)
NO (1) NO973122L (es)
WO (1) WO1997017974A1 (es)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6232343B1 (en) * 1996-05-07 2001-05-15 Toray Industries, Inc. Ophthalmic preparations
US7439372B2 (en) * 2006-05-03 2008-10-21 Allergan, Inc. Therapeutic compounds
US20090016981A1 (en) 2006-05-03 2009-01-15 Allergan, Inc. Therapeutic compounds
EP2343292B1 (en) * 2008-09-10 2014-08-06 Asahi Glass Company, Limited Novel prostaglandin i2 derivative
BR112012022632B1 (pt) * 2010-03-08 2020-03-31 Kaken Pharmaceutical Co., Ltd. Medicamento compreendendo Agonista de ep4

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2476684A1 (fr) * 1980-02-21 1981-08-28 Interox Procede pour inhiber la corrosion d'appareils en titane
EP0232776B1 (en) * 1986-01-24 1990-10-24 Toray Industries, Inc. 2,5,6,7-tetranor-4,8-inter-m-phenylene pgi2 derivatives
DE3886936T2 (de) * 1987-10-16 1994-04-28 Toray Industries 2,5,6,7-TETRANOR-4,8-INTER-m-PHENYLEN 2-PGI-DERIVATE, VERFAHREN ZUR HERSTELLUNG UND DEREN VERWENDUNG.
US6232343B1 (en) * 1996-05-07 2001-05-15 Toray Industries, Inc. Ophthalmic preparations

Also Published As

Publication number Publication date
AU717104B2 (en) 2000-03-16
CN1127342C (zh) 2003-11-12
EP0795331A1 (en) 1997-09-17
WO1997017974A1 (fr) 1997-05-22
NO973122D0 (no) 1997-07-04
EP0795331A4 (en) 1999-07-14
CN1177926A (zh) 1998-04-01
EP0795331B1 (en) 2002-04-10
CA2210255A1 (en) 1997-05-22
US6127413A (en) 2000-10-03
DE69620573T2 (de) 2002-08-08
NO973122L (no) 1997-08-27
KR19980701417A (ko) 1998-05-15
DE69620573D1 (de) 2002-05-16
AU7587396A (en) 1997-06-05
ATE215824T1 (de) 2002-04-15

Similar Documents

Publication Publication Date Title
LU91943I2 (fr) Tafluprost et ses dérivés pharmaceutiquement acceptables (SAFLUTAN®)
LU90969I2 (fr) Compositions ophtalmiques topiques contenant olopatadine destinees au tritement d'affections allergiques des yeux
FI902258A0 (fi) Menetelmä farmakologisesti aktiivisten 13,14-dihydro-17-fenyyli-18,19,20-trinor-PGF2 -alkyyliestereiden valmistamiseksi
LU92509I2 (fr) Travoprost et ses dérivés pharmaceutiquement acceptables (TRAVATAN)
KR930001913A (ko) 안염 치료방법
HUT68385A (en) Polypeptide and process for producing thereof
AU2231797A (en) Novel iridoid derivatives and a vascularization inhibitor having for its active ingredient said derivative
ATE111736T1 (de) Okulare hypotensive mittel.
ATE359794T1 (de) 3, 7 thiaprostansäurederivate als mittel zur verminderung des augeninnendruckes
BR0017157A (pt) Derivados de 6-hidroxi-indazol para o tratamento de glaucoma
AU5446299A (en) Medicinal compositions for treating eye diseases
CA2234247A1 (en) An agent for curing ophthalmological diseases
HK1061645A1 (en) 3, 7 or 3 and 7 thia or oxa prostanoic acid derivatives as agents for lowering intraocular pressure
AU3453493A (en) Pharmaceutical preparation based on rhamnolipid against dermatological diseases, e.g. papilloma virus infections
PE106998A1 (es) Composiciones oftalmicas
ES2171742T3 (es) Agente reductor de la presion ocular.
WO1995034302A3 (en) Method for reducing intraocular pressure in the mammalian eye by administration of calcium chelators
FI964303A0 (fi) Keuhkosydänvian hoitamiseen tarkoitettu aine
AU1645897A (en) Benzopyran derivative and use of said benzopyran derivative for treating heart disease
ATE289817T1 (de) Arzneimittelzusammenstellung zur behandlung des erhöhten augeninnendrucks oder des glaukom
DK0749977T3 (da) Nye 17-hydroxyiminoalkyl- og 17-hydroxyiminomethylalkenylcyclopentanperhydrophenanthrenderivater aktive på det cardiovaskul
CA2219280A1 (en) Method for reducing intraocular pressure in the mammalian eye by administration of potassium channel blockers
WO2001082913A3 (en) Use of benzamide derivatives for the treatment of high ocular tension and glaucoma
TH59045B (th) อนุพันธ์อินโดลและสารผสมทางเภสัชกรรมที่ประกอบด้วยสารดังกล่าว

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 795331

Country of ref document: ES